Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a revenue of 362 million yuan for 2025, representing a year-on-year growth of 16.63%, and a net profit attributable to shareholders of 42.13 million yuan, which is a significant increase of 222.30% year-on-year [4] - The company is expected to maintain strong growth, with projected net profits for 2026-2028 at 53 million yuan, 64 million yuan, and 81 million yuan respectively, corresponding to EPS of 0.62, 0.75, and 0.95 yuan per share [4] - The company is actively engaged in the development of high-end scientific instruments and has made significant advancements in product automation and intelligence [5][6] Financial Summary - Revenue is projected to grow from 362 million yuan in 2025 to 434 million yuan in 2026, 499 million yuan in 2027, and 606 million yuan in 2028, with respective year-on-year growth rates of 19.9%, 14.9%, and 21.4% [9] - The gross margin is expected to remain stable, with estimates of 65.1% in 2026, 64.9% in 2027, and 65.5% in 2028 [10] - The net profit margin is projected to improve from 10.7% in 2025 to 10.6% in 2026, 11.9% in 2027, and 12.9% in 2028 [10] - The company has maintained a strong return on equity (ROE), expected to rise from 8.7% in 2025 to 9.4% in 2026, 11.0% in 2027, and 12.8% in 2028 [10] Product Development and Market Position - The company launched the high-end N70 Fourier Transform Near-Infrared Spectrometer in September 2025, which is applicable in various fields such as pharmaceuticals, chemicals, and food [5] - The company has invested 54.11 million yuan in R&D, accounting for 14.96% of its revenue, and has obtained 15 new invention patents and 11 utility model patents [6] - The company is focusing on domestic high-demand sectors and international high-end markets, enhancing its competitive edge through product innovation and automation [5][6]
海能技术（920476）：北交所信息更新：投资安益谱拓展质谱仪领域，积极进行产品智能化自动化改造